• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本神经血管治疗注册研究 3 中穿刺部位相关并发症分析。

Analysis of Puncture Site-related Complications in Japanese Registry of Neuroendovascular Therapy (JR-NET)3.

机构信息

Department of Neurosurgery, Faculty of Medicine, University of Tsukuba.

Department of Neurosurgery and Comprehensive Stroke Center, Kobe City Medical Center General Hospital.

出版信息

Neurol Med Chir (Tokyo). 2020 May 15;60(5):271-275. doi: 10.2176/nmc.oa.2019-0243. Epub 2020 Apr 15.

DOI:10.2176/nmc.oa.2019-0243
PMID:32295980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7246228/
Abstract

A subgroup analysis of puncture site-related complications listed in the Japanese Registry of NeuroEndovascular Therapy 3, based on retrospective studies, was performed. Puncture site-related complications occurred in 315 (0.73%, average age: 65.2) of 36,708 patients out of all 43,303 registered cases. Carotid artery stenting (CAS, 95 patients, 1.1%, P <0.01) and extracranial percutaneous transluminal angioplasty (PTA, 21 patients, 1.4%, P <0.01) were associated with significantly higher incidence of puncture site-related complications. The incidence of complications correlated with the number of antiplatelet drugs (P <0.001). Although 40% of the puncture complications were treated conservatively, 13% were treated endovascularly and 5% underwent open surgery.

摘要

基于回顾性研究,对日本神经血管治疗注册研究 3 中列出的穿刺部位相关并发症进行了亚组分析。在所有登记的 43303 例患者中,有 315 例(0.73%,平均年龄:65.2 岁)发生了穿刺部位相关并发症。颈动脉支架置入术(CAS,95 例,1.1%,P<0.01)和颅外经皮腔内血管成形术(PTA,21 例,1.4%,P<0.01)与穿刺部位相关并发症的发生率显著增加相关。并发症的发生率与抗血小板药物的数量相关(P<0.001)。虽然 40%的穿刺并发症采用保守治疗,但有 13%采用了血管内治疗,5%采用了开放手术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924d/7246228/b2af11cdc372/nmc-60-271-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924d/7246228/b2af11cdc372/nmc-60-271-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924d/7246228/b2af11cdc372/nmc-60-271-g1.jpg

相似文献

1
Analysis of Puncture Site-related Complications in Japanese Registry of Neuroendovascular Therapy (JR-NET)3.日本神经血管治疗注册研究 3 中穿刺部位相关并发症分析。
Neurol Med Chir (Tokyo). 2020 May 15;60(5):271-275. doi: 10.2176/nmc.oa.2019-0243. Epub 2020 Apr 15.
2
Detailed Analysis of Puncture Site Vascular Complications in Japanese Registry of Neuroendovascular Therapy (JR-NET) and JR-NET2.日本神经血管内治疗登记处(JR-NET)和JR-NET2中穿刺部位血管并发症的详细分析。
Neurol Med Chir (Tokyo). 2014;54 Suppl 2:17-22.
3
Detailed analysis of puncture site vascular complications in Japanese Registry of Neuroendovascular Therapy (JR-NET) and JR-NET2.日本神经血管内治疗注册研究(JR-NET)和JR-NET2中穿刺部位血管并发症的详细分析。
Neurol Med Chir (Tokyo). 2014;54(1):17-22. doi: 10.2176/nmc.oa2013-0196. Epub 2013 Nov 20.
4
Current perioperative management of anticoagulant and antiplatelet use in neuroendovascular therapy: analysis of JR-NET1 and 2.神经血管内治疗中抗凝和抗血小板药物使用的当前围手术期管理:JR-NET1和2分析
Neurol Med Chir (Tokyo). 2014;54 Suppl 2:9-16.
5
Endovascular Therapy for Intracranial Artery Stenosis: Results from the Japanese Registry of Neuroendovascular Therapy (JR-NET)3.颅内动脉狭窄血管内治疗:日本神经血管内治疗登记研究(JR-NET)3 期结果。
Neurol Med Chir (Tokyo). 2020 May 15;60(5):256-263. doi: 10.2176/nmc.oa.2019-0271. Epub 2020 Apr 15.
6
Real-world Experience of Carotid Artery Stenting in Japan: Analysis of 8458 Cases from the JR-NET3 Nationwide Retrospective Multi-center Registries.日本颈动脉支架置入术的真实世界经验:来自JR-NET3全国性回顾性多中心注册研究的8458例病例分析。
Neurol Med Chir (Tokyo). 2019 Apr 15;59(4):117-125. doi: 10.2176/nmc.st.2018-0264. Epub 2019 Mar 15.
7
The Current Status of Endovascular Treatment for Extracranial Steno-occlusive Diseases in Japan: Analysis Using the Japanese Registry of Neuroendovascular Therapy 3 (JR-NET3).日本颅外狭窄闭塞性疾病血管内治疗的现状:使用日本神经血管内治疗注册研究3(JR-NET3)进行的分析
Neurol Med Chir (Tokyo). 2020 Jan 15;60(1):1-9. doi: 10.2176/nmc.st.2018-0315. Epub 2019 Nov 21.
8
Real-world Experience of Carotid Artery Stentingin Japan: Analysis of 7,134 Cases from JR-NET1 and 2Nationwide Retrospective Multi-center Registries.日本颈动脉支架置入术的真实世界经验:对来自JR-NET1和2全国性回顾性多中心注册研究的7134例病例的分析。
Neurol Med Chir (Tokyo). 2014;54 Suppl 2:32-9.
9
Real-world experience of carotid artery stenting in Japan: analysis of 7,134 cases from JR-NET1 and 2 nationwide retrospective multi-center registries.日本颈动脉支架置入术的真实世界经验:来自JR-NET1和2全国性回顾性多中心登记处的7134例病例分析。
Neurol Med Chir (Tokyo). 2014;54(1):32-9. doi: 10.2176/nmc.oa2013-0187. Epub 2013 Dec 5.
10
Recent trends in neuroendovascular therapy in Japan: analysis of a nationwide survey--Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2.日本神经血管内治疗的近期趋势:一项全国性调查分析——日本神经血管内治疗登记处(JR-NET)1和2
Neurol Med Chir (Tokyo). 2014;54 Suppl 2:1-8. doi: 10.2176/nmc.suppl.2014-2.

引用本文的文献

1
Comparative analysis of vascular closure devices for neuroendovascular procedures using Perclose versus Angioseal.使用Perclose与Angioseal进行神经血管内介入手术的血管闭合装置的对比分析。
Heliyon. 2024 Oct 30;10(21):e39975. doi: 10.1016/j.heliyon.2024.e39975. eCollection 2024 Nov 15.
2
Inferior Epigastric Artery Injury due to Femoral Venipuncture for Neuroendovascular Intervention: Two Cases Requiring Transcatheter Arterial Embolization.神经血管内介入治疗中股静脉穿刺导致的腹壁下动脉损伤:两例需要经导管动脉栓塞治疗的病例
J Neuroendovasc Ther. 2022;16(9):467-473. doi: 10.5797/jnet.cr.2022-0010. Epub 2022 May 12.

本文引用的文献

1
Closure of large bore 9 F arterial puncture sites with the AngioSeal STS device in acute stroke patients after intravenous recombinant tissue plasminogen activator (rt-PA).急性卒中患者静脉重组组织型纤溶酶原激活剂(rt-PA)治疗后应用 AngioSeal STS 装置闭合大口径 9F 动脉穿刺部位。
J Neurointerv Surg. 2019 Jan;11(1):28-30. doi: 10.1136/neurintsurg-2018-013829. Epub 2018 May 15.
2
Usefulness of an access-site hemostasis device in neuroendovascular treatment.一种穿刺部位止血装置在神经血管内治疗中的应用价值。
Acta Neurochir (Wien). 2017 Dec;159(12):2331-2335. doi: 10.1007/s00701-017-3299-5. Epub 2017 Aug 22.
3
Suitability of a 7-F ExoSeal Vascular Closure Device for Femoral Artery Punctures Made by 8-F or 9-F Introducer Sheaths.
7-F ExoSeal血管闭合装置用于由8-F或9-F穿刺鞘进行的股动脉穿刺的适用性。
J Endovasc Ther. 2017 Aug;24(4):516-520. doi: 10.1177/1526602817716642.
4
Detailed analysis of puncture site vascular complications in Japanese Registry of Neuroendovascular Therapy (JR-NET) and JR-NET2.日本神经血管内治疗注册研究(JR-NET)和JR-NET2中穿刺部位血管并发症的详细分析。
Neurol Med Chir (Tokyo). 2014;54(1):17-22. doi: 10.2176/nmc.oa2013-0196. Epub 2013 Nov 20.
5
The frequency of vascular complications associated with the use of vascular closure devices varies by indication for cardiac catheterization.血管闭合装置相关血管并发症的发生频率因心脏导管插入术的适应证而异。
Clin Res Cardiol. 2011 Sep;100(9):789-95. doi: 10.1007/s00392-011-0313-4. Epub 2011 Apr 11.
6
Arterial closure devices versus manual compression for femoral haemostasis in interventional radiological procedures: a systematic review and meta-analysis.动脉闭合装置与手动压迫在介入放射学程序中用于股动脉止血的比较:系统评价和荟萃分析。
Cardiovasc Intervent Radiol. 2011 Aug;34(4):723-38. doi: 10.1007/s00270-010-9981-0. Epub 2010 Oct 29.
7
A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital--the SCOAST study.一项在地区综合医院比较StarClose和AngioSeal血管闭合装置的随机对照试验——SCOAST研究。
Int J Clin Pract. 2008 Jun;62(6):912-8. doi: 10.1111/j.1742-1241.2008.01761.x.
8
Angioseal versus manual compression for haemostasis following peripheral vascular diagnostic and interventional procedures--a randomized controlled trial.外周血管诊断和介入操作后使用血管封堵器与手动压迫止血的比较——一项随机对照试验
Eur J Radiol. 2007 Feb;61(2):332-4. doi: 10.1016/j.ejrad.2006.09.007. Epub 2006 Oct 30.
9
A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention.诊断性心导管插入术和经皮冠状动脉介入治疗后经皮血管闭合装置的荟萃分析。
J Invasive Cardiol. 2004 May;16(5):243-6.
10
Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis.心脏导管插入术后动脉穿刺闭合装置与标准手动压迫的比较:系统评价与荟萃分析
JAMA. 2004 Jan 21;291(3):350-7. doi: 10.1001/jama.291.3.350.